GlassScriptPhysician profile
Victoria Atchison
NPI 1851801351
$4,231.52
in general payments reported to CMS, 2019-2025
40 companies · $1,034 in 2025
The $1,034 reported for 2025 was more than what 84% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $748 · 2022: $609 · 2023: $435 · 2024: $1,406 · 2025: $1,034.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,799 · Education: $74.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,799.11 |
| Education | $74.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $471.08 | 2023-2025 | Enhertu, Datroway, Injectafer |
| Genentech USA, INC. | $328.41 | 2021-2025 | Tecentriq, Phesgo, Perjeta |
| E.R. Squibb & Sons, L.L.C. | $327.80 | 2021-2025 | Opdivo, Eliquis |
| Janssen Biotech, INC. | $282.65 | 2024-2025 | Darzalex, Tecvayli, Carvykti |
| Genzyme Corporation | $248.80 | 2023-2025 | |
| Seagen INC. | $245.79 | 2022 | |
| Pfizer INC. | $211.49 | 2022-2024 | |
| Incyte Corporation | $182.57 | 2022-2025 | Monjuvi, Jakafi, Zynyz |
| Sobi, INC | $176.71 | 2022-2025 | |
| Gilead Sciences, INC. | $157.96 | 2024 | Trodelvy |
| Merck Sharp & Dohme LLC | $149.92 | 2024-2025 | Keytruda, Lynparza, Welireg |
| Teva Pharmaceuticals USA, INC. | $131.58 | 2021 | |
| Veloxis Pharmaceuticals, INC. | $126.56 | 2021 | |
| Amgen INC. | $120.09 | 2021 | |
| Geron Corporation | $115.70 | 2025 | Rytelo |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Victoria Atchison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.